Wyeth closing Penn. facility
Wyeth will be closing its West Chester, Penn. manufacturing facility effective December 2004. Wyeth ceased manufacturing its own products at the facility in fall 2004 and has been operating as a third party manufacturer to King and Baxter ever since. The facility was manufacturing bicillin and penicillin injectables for King and ampicillin and sulbactam for Baxter...
You may also be interested in...
Hopes that the Phase II TAURIEL trial could potentially validate the anti-tau antibody approach to treating Alzheimer's have been dashed as semorinemab did not meet its endpoints.
Indivior aims to cut costs by restructuring its US commercial operations and reducing discretionary spending, in order to improve flexibility in the face of the COVID-19 pandemic and to invest in R&D.
Look! Up in the sky! It’s a bird! It’s a plane! It’s … a COVID-19 test from Quest Diagnostics.